T. Rowe Price Associates’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q1 | – | Sell |
-23,465,722
| Closed | -$398M | – | 2619 |
|
|
2014
Q4 | $398M | Sell |
23,465,722
-4,581,500
| -16% | -$77.7M | 0.08% | 279 |
|
|
2014
Q3 | $334M | Buy |
28,047,222
+2,491,100
| +10% | +$29.7M | 0.07% | 306 |
|
|
2014
Q2 | $144M | Sell |
25,556,122
-97,620
| -0.4% | -$551K | 0.03% | 525 |
|
|
2014
Q1 | $94.1M | Buy |
25,653,742
+842,803
| +3% | +$3.09M | 0.02% | 651 |
|
|
2013
Q4 | $83.4M | Buy |
24,810,939
+3,426,128
| +16% | +$11.5M | 0.02% | 661 |
|
|
2013
Q3 | $90.7M | Sell |
21,384,811
-337,900
| -2% | -$1.43M | 0.02% | 619 |
|
|
2013
Q2 | $99.9M | Buy |
+21,722,711
| New | +$99.9M | 0.03% | 571 |
|